Catalyst Wire Dossier Catalyst Wire Dossier

NEORAL

CYCLOSPORINE · Novartis Pharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

28 regulatory and trial events tracked for NEORAL, covering 2006-05-22 to 2023-09-26. Get the full timeline:

Most recent: FDA Approved: NEORAL — Supplemental Application (Novartis Pharmaceuticals Corporation)

See pricing